MedTech Terms
    The authoritative reference
    All terms
    Quality & RiskQuality SystemPost-Market & SafetyGlobal Markets

    Warning Letter

    Formal FDA notification of significant violations requiring prompt corrective action.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed September 19, 2026

    Definition

    An FDA Warning Letter is a notice to a regulated entity citing significant violations and requesting prompt corrective action, typically within 15 business days. Warning letters are usually issued after an inspection where the 483 response was judged inadequate, or after other evidence of significant violations. They are published on FDA's website. Unresolved issues can lead to regulatory actions such as import alerts, seizure, injunction or civil money penalties, and FDA may withhold approval of related Class III submissions. Closure requires FDA to verify corrective actions, often through a follow-up inspection.
    What the regulation says
    The FDA issues Warning Letters to address violations of regulatory significance, as outlined in 21 CFR Part 820 for Quality System Regulation, 21 CFR Part 4 for combination products, and other applicable regulations like those found in 21 CFR Parts 801 and 809 for labeling and advertising. These letters serve as official communications indicating that the agency believes violations may lead to enforcement action if not promptly corrected. The FDA Field Management Directive (FMD) 140 provides guidance regarding the issuance and content of Warning Letters.

    What this means in practice

    Warning Letters are public and can affect new submissions, imports, and reputation. Repeat or unresolved issues can lead to seizures or injunctions.

    Examples

    • A medical device manufacturer receives a Warning Letter citing violations of 21 CFR 820.30, Quality System Design Controls, for inadequate design validation procedures related to a new product being marketed.
    • A pharmaceutical company is issued a Warning Letter due to repeated observations of unsanitary conditions and manufacturing deficiencies, which violate 21 CFR 211, Current Good Manufacturing Practice for Finished Pharmaceuticals.
    • An online retailer receives a Warning Letter for illegally marketing unapproved MedTech products with unsubstantiated claims, constituting a violation of the Federal Food, Drug, and Cosmetic Act.
    Common pitfalls
    • •Assuming a Warning Letter is merely a suggestion, rather than a formal communication of regulatory non-compliance that demands a response.
    • •Failing to address all cited observations in the Warning Letter, which can lead to further enforcement actions.
    • •Submitting a response without sufficient evidence or documentation of corrective actions.
    • •Delaying the response past the specified timeframe, typically 15 business days, without prior communication and agreement with the FDA.
    • •Underestimating the public and business impact of a Warning Letter, including potential effects on stock prices, contractual agreements, and reputation.

    Frequently asked questions

    An FDA Warning Letter serves to notify a regulated entity of significant deviations from regulatory requirements that, if not corrected, may result in enforcement actions. It is a formal communication demanding prompt corrective action.

    Related terms

    Grouped by theme
    Cited by

    Where this term appears across MedTech Terms.

    Learning paths (1)

    Sources

    3 sources

    Sources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

    Tier 2Regulator guidance and consensus· 2Tier 4Trade press and expert commentary· 1
    Link health: 3 verified· last checked 2026-06-20
    FDA·2MDIC·1
    1. 1
      FDA Warning Letters
      Tier 2 Verified
      FDAfda.gov
    2. 2
      MDIC Case for Quality
      Tier 4 Verified
      MDICmdic.org
    3. 3
      FDA - Quality Systems
      Tier 2 Verified
      FDAfda.gov

    Inline markers like [1] jump to the matching reference above.